Loading…
Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies
Highlights • Haploidentical and unrelated donor transplantation have similar risks of acute and chronic graft-versus-host disease • Haploidentical and unrelated donor recipients have similar probabilities of survival • Human Herpesvirus-6 reactivation is higher for haploidentical transplant recipien...
Saved in:
| Published in: | Biology of blood and marrow transplantation 2016-11, Vol.22 (11), p.2047-2055 |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c455t-eaccbcc9e2a077eedea5d0f8957de6d23021a0a6e1c57729b7572e881cf5d1cf3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c455t-eaccbcc9e2a077eedea5d0f8957de6d23021a0a6e1c57729b7572e881cf5d1cf3 |
| container_end_page | 2055 |
| container_issue | 11 |
| container_start_page | 2047 |
| container_title | Biology of blood and marrow transplantation |
| container_volume | 22 |
| creator | Baker, Melissa Wang, Hongkun Rowley, Scott D Cai, Ling Pecora, Andrew L Skarbnik, Alan Vesole, David H Adler-Brecher, Barbara Kim, Daniel Donato, Michele L |
| description | Highlights • Haploidentical and unrelated donor transplantation have similar risks of acute and chronic graft-versus-host disease • Haploidentical and unrelated donor recipients have similar probabilities of survival • Human Herpesvirus-6 reactivation is higher for haploidentical transplant recipients • Platelet recovery, but not neutrophil recovery, is faster using peripheral blood stem cells for haploidentical transplants • Haploidentical transplantation may achieve more robust early lymphoid engraftment |
| doi_str_mv | 10.1016/j.bbmt.2016.08.003 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835435105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1083879116302786</els_id><sourcerecordid>1835435105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-eaccbcc9e2a077eedea5d0f8957de6d23021a0a6e1c57729b7572e881cf5d1cf3</originalsourceid><addsrcrecordid>eNp9UsFuFSEUnRiNrdUfcGFYupkRmMfAJMakfVqfSZuatF0TBu5Ungy8AtOmH-O_lvFVFy7cwL3hnEPuObeq3hLcEEy6D9tmGKbc0FI3WDQYt8-qQ8JoW3es7Z6XGou2FrwnB9WrlLYYY74S_cvqgHJGKV7hw-rXOkw7FVW2d4Au5qzDBAmpMUNEG7VzwRrw2WrlUIjo2kdwKoNBn4Mv_UnwgM5VjOF-eT5xIRh0mWFCa3AOXUXl084pn4t-8Mh6dGxml9H30hfZhO5t_oE2MKkcXLj5_c25cvbGK68tpNfVi1G5BG-e7qPq-vTL1XpTn118_bY-Pqv1irFcg9J60LoHqjDnAAYUM3gUPeMGOkNbTInCqgOiGee0HzjjFIQgemSmHO1R9X6vu4vhdoaU5WSTLiMoD2FOkoiWrVpGMCtQuofqGFKKMMpdtJOKD5JgucQit3KJRS6xSCxkiaWQ3j3pz8ME5i_lTw4F8HEPgDLlnYUoU5nfazA2gs7SBPt__U__0LWzfrHzJzxA2oY5-uKfJDJRieXlshjLXpCuWMNF1z4Cux-3JA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835435105</pqid></control><display><type>article</type><title>Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies</title><source>ScienceDirect Journals</source><creator>Baker, Melissa ; Wang, Hongkun ; Rowley, Scott D ; Cai, Ling ; Pecora, Andrew L ; Skarbnik, Alan ; Vesole, David H ; Adler-Brecher, Barbara ; Kim, Daniel ; Donato, Michele L</creator><creatorcontrib>Baker, Melissa ; Wang, Hongkun ; Rowley, Scott D ; Cai, Ling ; Pecora, Andrew L ; Skarbnik, Alan ; Vesole, David H ; Adler-Brecher, Barbara ; Kim, Daniel ; Donato, Michele L</creatorcontrib><description>Highlights • Haploidentical and unrelated donor transplantation have similar risks of acute and chronic graft-versus-host disease • Haploidentical and unrelated donor recipients have similar probabilities of survival • Human Herpesvirus-6 reactivation is higher for haploidentical transplant recipients • Platelet recovery, but not neutrophil recovery, is faster using peripheral blood stem cells for haploidentical transplants • Haploidentical transplantation may achieve more robust early lymphoid engraftment</description><identifier>ISSN: 1083-8791</identifier><identifier>EISSN: 1523-6536</identifier><identifier>DOI: 10.1016/j.bbmt.2016.08.003</identifier><identifier>PMID: 27522040</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Bone Marrow Transplantation - adverse effects ; Bone Marrow Transplantation - methods ; Bone Marrow Transplantation - mortality ; Chimerism ; Cyclophosphamide - therapeutic use ; Female ; Graft Survival ; Graft vs Host Disease - prevention & control ; Haploidentical transplantation ; Hematologic Neoplasms - complications ; Hematologic Neoplasms - mortality ; Hematologic Neoplasms - therapy ; Hematology, Oncology and Palliative Medicine ; Humans ; Male ; Middle Aged ; Peripheral Blood Stem Cell Transplantation - adverse effects ; Peripheral Blood Stem Cell Transplantation - methods ; Peripheral Blood Stem Cell Transplantation - mortality ; Post-transplantation cyclophosphamide ; Premedication ; Survival Analysis ; Transplantation, Haploidentical - adverse effects ; Transplantation, Haploidentical - mortality ; Treatment Outcome ; Unrelated donor transplantation ; Unrelated Donors ; Virus Activation ; Young Adult</subject><ispartof>Biology of blood and marrow transplantation, 2016-11, Vol.22 (11), p.2047-2055</ispartof><rights>The American Society for Blood and Marrow Transplantation</rights><rights>2016 The American Society for Blood and Marrow Transplantation</rights><rights>Copyright © 2016 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-eaccbcc9e2a077eedea5d0f8957de6d23021a0a6e1c57729b7572e881cf5d1cf3</citedby><cites>FETCH-LOGICAL-c455t-eaccbcc9e2a077eedea5d0f8957de6d23021a0a6e1c57729b7572e881cf5d1cf3</cites><orcidid>0000-0002-1276-7546 ; 0000-0002-3299-835X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27522040$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Baker, Melissa</creatorcontrib><creatorcontrib>Wang, Hongkun</creatorcontrib><creatorcontrib>Rowley, Scott D</creatorcontrib><creatorcontrib>Cai, Ling</creatorcontrib><creatorcontrib>Pecora, Andrew L</creatorcontrib><creatorcontrib>Skarbnik, Alan</creatorcontrib><creatorcontrib>Vesole, David H</creatorcontrib><creatorcontrib>Adler-Brecher, Barbara</creatorcontrib><creatorcontrib>Kim, Daniel</creatorcontrib><creatorcontrib>Donato, Michele L</creatorcontrib><title>Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies</title><title>Biology of blood and marrow transplantation</title><addtitle>Biol Blood Marrow Transplant</addtitle><description>Highlights • Haploidentical and unrelated donor transplantation have similar risks of acute and chronic graft-versus-host disease • Haploidentical and unrelated donor recipients have similar probabilities of survival • Human Herpesvirus-6 reactivation is higher for haploidentical transplant recipients • Platelet recovery, but not neutrophil recovery, is faster using peripheral blood stem cells for haploidentical transplants • Haploidentical transplantation may achieve more robust early lymphoid engraftment</description><subject>Adult</subject><subject>Aged</subject><subject>Bone Marrow Transplantation - adverse effects</subject><subject>Bone Marrow Transplantation - methods</subject><subject>Bone Marrow Transplantation - mortality</subject><subject>Chimerism</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Female</subject><subject>Graft Survival</subject><subject>Graft vs Host Disease - prevention & control</subject><subject>Haploidentical transplantation</subject><subject>Hematologic Neoplasms - complications</subject><subject>Hematologic Neoplasms - mortality</subject><subject>Hematologic Neoplasms - therapy</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Peripheral Blood Stem Cell Transplantation - adverse effects</subject><subject>Peripheral Blood Stem Cell Transplantation - methods</subject><subject>Peripheral Blood Stem Cell Transplantation - mortality</subject><subject>Post-transplantation cyclophosphamide</subject><subject>Premedication</subject><subject>Survival Analysis</subject><subject>Transplantation, Haploidentical - adverse effects</subject><subject>Transplantation, Haploidentical - mortality</subject><subject>Treatment Outcome</subject><subject>Unrelated donor transplantation</subject><subject>Unrelated Donors</subject><subject>Virus Activation</subject><subject>Young Adult</subject><issn>1083-8791</issn><issn>1523-6536</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9UsFuFSEUnRiNrdUfcGFYupkRmMfAJMakfVqfSZuatF0TBu5Ungy8AtOmH-O_lvFVFy7cwL3hnEPuObeq3hLcEEy6D9tmGKbc0FI3WDQYt8-qQ8JoW3es7Z6XGou2FrwnB9WrlLYYY74S_cvqgHJGKV7hw-rXOkw7FVW2d4Au5qzDBAmpMUNEG7VzwRrw2WrlUIjo2kdwKoNBn4Mv_UnwgM5VjOF-eT5xIRh0mWFCa3AOXUXl084pn4t-8Mh6dGxml9H30hfZhO5t_oE2MKkcXLj5_c25cvbGK68tpNfVi1G5BG-e7qPq-vTL1XpTn118_bY-Pqv1irFcg9J60LoHqjDnAAYUM3gUPeMGOkNbTInCqgOiGee0HzjjFIQgemSmHO1R9X6vu4vhdoaU5WSTLiMoD2FOkoiWrVpGMCtQuofqGFKKMMpdtJOKD5JgucQit3KJRS6xSCxkiaWQ3j3pz8ME5i_lTw4F8HEPgDLlnYUoU5nfazA2gs7SBPt__U__0LWzfrHzJzxA2oY5-uKfJDJRieXlshjLXpCuWMNF1z4Cux-3JA</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Baker, Melissa</creator><creator>Wang, Hongkun</creator><creator>Rowley, Scott D</creator><creator>Cai, Ling</creator><creator>Pecora, Andrew L</creator><creator>Skarbnik, Alan</creator><creator>Vesole, David H</creator><creator>Adler-Brecher, Barbara</creator><creator>Kim, Daniel</creator><creator>Donato, Michele L</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1276-7546</orcidid><orcidid>https://orcid.org/0000-0002-3299-835X</orcidid></search><sort><creationdate>20161101</creationdate><title>Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies</title><author>Baker, Melissa ; Wang, Hongkun ; Rowley, Scott D ; Cai, Ling ; Pecora, Andrew L ; Skarbnik, Alan ; Vesole, David H ; Adler-Brecher, Barbara ; Kim, Daniel ; Donato, Michele L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-eaccbcc9e2a077eedea5d0f8957de6d23021a0a6e1c57729b7572e881cf5d1cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Bone Marrow Transplantation - adverse effects</topic><topic>Bone Marrow Transplantation - methods</topic><topic>Bone Marrow Transplantation - mortality</topic><topic>Chimerism</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Female</topic><topic>Graft Survival</topic><topic>Graft vs Host Disease - prevention & control</topic><topic>Haploidentical transplantation</topic><topic>Hematologic Neoplasms - complications</topic><topic>Hematologic Neoplasms - mortality</topic><topic>Hematologic Neoplasms - therapy</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Peripheral Blood Stem Cell Transplantation - adverse effects</topic><topic>Peripheral Blood Stem Cell Transplantation - methods</topic><topic>Peripheral Blood Stem Cell Transplantation - mortality</topic><topic>Post-transplantation cyclophosphamide</topic><topic>Premedication</topic><topic>Survival Analysis</topic><topic>Transplantation, Haploidentical - adverse effects</topic><topic>Transplantation, Haploidentical - mortality</topic><topic>Treatment Outcome</topic><topic>Unrelated donor transplantation</topic><topic>Unrelated Donors</topic><topic>Virus Activation</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Baker, Melissa</creatorcontrib><creatorcontrib>Wang, Hongkun</creatorcontrib><creatorcontrib>Rowley, Scott D</creatorcontrib><creatorcontrib>Cai, Ling</creatorcontrib><creatorcontrib>Pecora, Andrew L</creatorcontrib><creatorcontrib>Skarbnik, Alan</creatorcontrib><creatorcontrib>Vesole, David H</creatorcontrib><creatorcontrib>Adler-Brecher, Barbara</creatorcontrib><creatorcontrib>Kim, Daniel</creatorcontrib><creatorcontrib>Donato, Michele L</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biology of blood and marrow transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Baker, Melissa</au><au>Wang, Hongkun</au><au>Rowley, Scott D</au><au>Cai, Ling</au><au>Pecora, Andrew L</au><au>Skarbnik, Alan</au><au>Vesole, David H</au><au>Adler-Brecher, Barbara</au><au>Kim, Daniel</au><au>Donato, Michele L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies</atitle><jtitle>Biology of blood and marrow transplantation</jtitle><addtitle>Biol Blood Marrow Transplant</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>22</volume><issue>11</issue><spage>2047</spage><epage>2055</epage><pages>2047-2055</pages><issn>1083-8791</issn><eissn>1523-6536</eissn><abstract>Highlights • Haploidentical and unrelated donor transplantation have similar risks of acute and chronic graft-versus-host disease • Haploidentical and unrelated donor recipients have similar probabilities of survival • Human Herpesvirus-6 reactivation is higher for haploidentical transplant recipients • Platelet recovery, but not neutrophil recovery, is faster using peripheral blood stem cells for haploidentical transplants • Haploidentical transplantation may achieve more robust early lymphoid engraftment</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27522040</pmid><doi>10.1016/j.bbmt.2016.08.003</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-1276-7546</orcidid><orcidid>https://orcid.org/0000-0002-3299-835X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1083-8791 |
| ispartof | Biology of blood and marrow transplantation, 2016-11, Vol.22 (11), p.2047-2055 |
| issn | 1083-8791 1523-6536 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1835435105 |
| source | ScienceDirect Journals |
| subjects | Adult Aged Bone Marrow Transplantation - adverse effects Bone Marrow Transplantation - methods Bone Marrow Transplantation - mortality Chimerism Cyclophosphamide - therapeutic use Female Graft Survival Graft vs Host Disease - prevention & control Haploidentical transplantation Hematologic Neoplasms - complications Hematologic Neoplasms - mortality Hematologic Neoplasms - therapy Hematology, Oncology and Palliative Medicine Humans Male Middle Aged Peripheral Blood Stem Cell Transplantation - adverse effects Peripheral Blood Stem Cell Transplantation - methods Peripheral Blood Stem Cell Transplantation - mortality Post-transplantation cyclophosphamide Premedication Survival Analysis Transplantation, Haploidentical - adverse effects Transplantation, Haploidentical - mortality Treatment Outcome Unrelated donor transplantation Unrelated Donors Virus Activation Young Adult |
| title | Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T17%3A53%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20Outcomes%20after%20Haploidentical%20or%20Unrelated%20Donor%20Bone%20Marrow%20or%20Blood%20Stem%20Cell%20Transplantation%20in%20Adult%20Patients%20with%20Hematological%20Malignancies&rft.jtitle=Biology%20of%20blood%20and%20marrow%20transplantation&rft.au=Baker,%20Melissa&rft.date=2016-11-01&rft.volume=22&rft.issue=11&rft.spage=2047&rft.epage=2055&rft.pages=2047-2055&rft.issn=1083-8791&rft.eissn=1523-6536&rft_id=info:doi/10.1016/j.bbmt.2016.08.003&rft_dat=%3Cproquest_cross%3E1835435105%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-eaccbcc9e2a077eedea5d0f8957de6d23021a0a6e1c57729b7572e881cf5d1cf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835435105&rft_id=info:pmid/27522040&rfr_iscdi=true |